# Kenvue Inc.

Summary updated: 2026-09-28T11:31:31.65905Z
Canonical: https://finbar.com/research/companies/kenvue

## Overview

Kenvue Inc. is a consumer health company whose products span self-care, skin health and beauty, and essential health. Its portfolio includes over-the-counter medicines and products for skin care, oral care, baby care and wound care, with brands such as Tylenol, Neutrogena, Listerine and BAND-AID Brand. Kenvue states that its purpose is “to realize the extraordinary power of everyday care.” [1](https://app.finbar.com/go?id=P112920323)[2](https://app.finbar.com/go?id=P9477289)[3](https://app.finbar.com/go?id=P6470689)[4](https://app.finbar.com/go?id=P78580457)[5](https://app.finbar.com/go?id=P11011656)

Kenvue markets products in more than 165 countries across North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. It reported $15.1 billion in net sales for 2025 and describes its workforce as numbering more than 20,000. The company became independent following its separation from Johnson & Johnson in 2023. [6](https://app.finbar.com/go?id=P106026927)[7](https://app.finbar.com/go?id=T7615640)[8](https://investors.kenvue.com/overview/)[9](https://app.finbar.com/go?id=P31934198)
[1](https://app.finbar.com/go?id=P112920323)[2](https://app.finbar.com/go?id=P9477289)[3](https://app.finbar.com/go?id=P6470689)[4](https://app.finbar.com/go?id=P78580457)[5](https://app.finbar.com/go?id=P11011656)[6](https://app.finbar.com/go?id=P106026927)[7](https://app.finbar.com/go?id=T7615640)[9](https://app.finbar.com/go?id=P31934198)[8](https://investors.kenvue.com/overview/)

## Products & services

Kenvue’s Self Care products include over-the-counter medicines and other products for coughs, colds, allergies, pain, digestive health, smoking cessation and eye care. Its brands include Tylenol, Zyrtec, Benadryl, Motrin, Nicorette and Zarbee’s. Tylenol Regular Strength tablets contain acetaminophen for pain relief and fever reduction; Zyrtec tablets contain the antihistamine cetirizine hydrochloride for allergy symptoms. Kenvue also describes digital diagnostics and telemedicine among its connected-health offerings. Self Care accounted for about 42% of 2025 net sales. [10](https://app.finbar.com/go?id=P80185027)[11](https://www.tylenol.com/products/headache-pain-relief/tylenol-regular-strength-tablets)[12](https://www.zyrtec.com/products/zyrtec-tablets)[13](https://app.finbar.com/go?id=T876864)
[10](https://app.finbar.com/go?id=P80185027)[13](https://app.finbar.com/go?id=T876864)[14](https://app.finbar.com/go?id=P29854779)[13](https://app.finbar.com/go?id=T876864)[15](https://app.finbar.com/go?id=P92932744)[13](https://app.finbar.com/go?id=T876864)[11](https://www.tylenol.com/products/headache-pain-relief/tylenol-regular-strength-tablets)[12](https://www.zyrtec.com/products/zyrtec-tablets)[16](https://www.neutrogena.com/products/sun/clear-face-break-out-free-liquid-lotion-sunscreen-broad-spectrum-spf-50/6811282)[17](https://www.kenvue.com/news-features/how-oat-soothes-locks-in-moisture-nourishes-skin)[18](https://www.kenvue.com/band-aid-brand-adhesive-bandages)[19](https://www.kenvue.com/johnsons-baby)

## Geographic presence

Kenvue’s sales span four reported regions. In fiscal 2025, North America accounted for $7.26 billion, or about 48% of net sales; Europe, the Middle East and Africa for $3.72 billion (25%); Asia-Pacific for $2.78 billion (18%); and Latin America for $1.37 billion (9%). Sales are assigned by customer location, and Kenvue does not separately disclose U.S. sales in this regional breakdown. [20](https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/kvue-20251228.htm)

Kenvue’s global headquarters is in Summit, New Jersey. At the end of fiscal 2025, it had approximately 22,000 employees, distributed across North America (23%), Europe, the Middle East and Africa (28%), Asia-Pacific (30%) and Latin America (19%). It reported approximately 120 sites worldwide, including 11 in the United States and 109 in other countries and territories. These sites serve functions including administration, research and development, manufacturing, warehousing and distribution. [21](https://investors.kenvue.com/resources/investor-br-faqs/default.aspx)[22](https://app.finbar.com/go?id=P54541588)[23](https://app.finbar.com/go?id=P70950294)
[24](https://app.finbar.com/go?id=T650005)[22](https://app.finbar.com/go?id=P54541588)[23](https://app.finbar.com/go?id=P70950294)[20](https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/kvue-20251228.htm)[21](https://investors.kenvue.com/resources/investor-br-faqs/default.aspx)

## Business segments

Kenvue reports three business segments. **Self Care** covers cough, cold and allergy products, pain care, and other categories including digestive health, smoking cessation and eye care; its brands include Tylenol, Zyrtec, Motrin and Nicorette. [10](https://app.finbar.com/go?id=P80185027) **Skin Health and Beauty** covers face and body care, hair care, sun care and related products, with brands including Neutrogena, Aveeno and OGX. [14](https://app.finbar.com/go?id=P29854779) **Essential Health** covers oral care, baby care, women’s health, wound care and related products; its brands include Listerine, Johnson’s and BAND-AID Brand. [15](https://app.finbar.com/go?id=P92932744)

In fiscal 2025, Self Care accounted for approximately **42%** of net sales, Skin Health and Beauty **27%**, and Essential Health **31%**. [25](https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/R50.htm)
[10](https://app.finbar.com/go?id=P80185027)[14](https://app.finbar.com/go?id=P29854779)[15](https://app.finbar.com/go?id=P92932744)[13](https://app.finbar.com/go?id=T876864)[13](https://app.finbar.com/go?id=T876864)[13](https://app.finbar.com/go?id=T876864)[25](https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/R50.htm)

## Company history

Kenvue’s history begins with the consumer-health businesses of Johnson & Johnson, founded in 1886. Johnson & Johnson marketed baby powder by 1894, acquired McNeil Laboratories—the company behind Tylenol—in 1959, and expanded its consumer portfolio in 2006 by acquiring Pfizer Consumer Healthcare, which included brands such as Listerine and Nicorette. [26](https://www.jnj.com/CH/our-company-history)[27](https://www.americanhistory.si.edu/collections/object-groups/health-hygiene-and-beauty/baby-products)[28](https://www.nytimes.com/1959/01/17/archives/drug-concern-sold-mcneil-laboratories-bought-by-johnson-johnson.html)[29](https://www.sec.gov/Archives/edgar/data/200406/000020040606000166/exhibitninetynineone.txt)

Johnson & Johnson announced plans to separate its Consumer Health business in 2021 and introduced Kenvue as the planned company’s name in 2022. Kenvue began trading on the New York Stock Exchange in May 2023 and became fully independent from Johnson & Johnson in August 2023. [30](https://www.investor.jnj.com/investor-news/news-details/2021/Johnson-Johnson-Announces-Plans-to-Accelerate-Innovation-Serve-Patients-and-Consumers-and-Unlock-Value-through-Intent-to-Separate-Consumer-Health-Business-11-12-2021/default.aspx)[31](https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-kenvue-as-the-name-for-planned-new-consumer-health-company)[32](https://www.kenvue.com/media/kenvue-trading-on-nyse)[33](https://www.kenvue.com/media/kenvue-becomes-a-fully-independent-company)
[26](https://www.jnj.com/CH/our-company-history)[27](https://www.americanhistory.si.edu/collections/object-groups/health-hygiene-and-beauty/baby-products)[28](https://www.nytimes.com/1959/01/17/archives/drug-concern-sold-mcneil-laboratories-bought-by-johnson-johnson.html)[29](https://www.sec.gov/Archives/edgar/data/200406/000020040606000166/exhibitninetynineone.txt)[30](https://www.investor.jnj.com/investor-news/news-details/2021/Johnson-Johnson-Announces-Plans-to-Accelerate-Innovation-Serve-Patients-and-Consumers-and-Unlock-Value-through-Intent-to-Separate-Consumer-Health-Business-11-12-2021/default.aspx)[31](https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-kenvue-as-the-name-for-planned-new-consumer-health-company)[32](https://www.kenvue.com/media/kenvue-trading-on-nyse)[33](https://www.kenvue.com/media/kenvue-becomes-a-fully-independent-company)

## Sources

1. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P112920323)
2. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P9477289)
3. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P6470689)
4. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P78580457)
5. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P11011656)
6. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P106026927)
7. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=T7615640)
8. [investors.kenvue.com](https://investors.kenvue.com/overview/)
9. [Kenvue Inc. — Full financial report (2024 Y)](https://app.finbar.com/go?id=P31934198)
10. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P80185027)
11. [www.tylenol.com](https://www.tylenol.com/products/headache-pain-relief/tylenol-regular-strength-tablets)
12. [www.zyrtec.com](https://www.zyrtec.com/products/zyrtec-tablets)
13. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=T876864)
14. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P29854779)
15. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P92932744)
16. [www.neutrogena.com](https://www.neutrogena.com/products/sun/clear-face-break-out-free-liquid-lotion-sunscreen-broad-spectrum-spf-50/6811282)
17. [www.kenvue.com](https://www.kenvue.com/news-features/how-oat-soothes-locks-in-moisture-nourishes-skin)
18. [www.kenvue.com](https://www.kenvue.com/band-aid-brand-adhesive-bandages)
19. [www.kenvue.com](https://www.kenvue.com/johnsons-baby)
20. [www.sec.gov](https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/kvue-20251228.htm)
21. [investors.kenvue.com](https://investors.kenvue.com/resources/investor-br-faqs/default.aspx)
22. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P54541588)
23. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P70950294)
24. [Kenvue Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=T650005)
25. [www.sec.gov](https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/R50.htm)
26. [www.jnj.com](https://www.jnj.com/CH/our-company-history)
27. [www.americanhistory.si.edu](https://www.americanhistory.si.edu/collections/object-groups/health-hygiene-and-beauty/baby-products)
28. [www.nytimes.com](https://www.nytimes.com/1959/01/17/archives/drug-concern-sold-mcneil-laboratories-bought-by-johnson-johnson.html)
29. [www.sec.gov](https://www.sec.gov/Archives/edgar/data/200406/000020040606000166/exhibitninetynineone.txt)
30. [www.investor.jnj.com](https://www.investor.jnj.com/investor-news/news-details/2021/Johnson-Johnson-Announces-Plans-to-Accelerate-Innovation-Serve-Patients-and-Consumers-and-Unlock-Value-through-Intent-to-Separate-Consumer-Health-Business-11-12-2021/default.aspx)
31. [www.jnj.com](https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-kenvue-as-the-name-for-planned-new-consumer-health-company)
32. [www.kenvue.com](https://www.kenvue.com/media/kenvue-trading-on-nyse)
33. [www.kenvue.com](https://www.kenvue.com/media/kenvue-becomes-a-fully-independent-company)

AI-generated summary; may contain errors. Not investment advice. Sign up to Finbar to view original document sources and access worldwide fundamental financial data and intelligence.